Alpine Partners VI »

G1 Therapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of G1 Therapeutics shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $107k 47k 2.28
2022-12-31 $131k 24k 5.44
2019-12-31 $417k 16k 26.46

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Microstrategy Cl A New (MSTR)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Microsoft Corporation (MSFT)
Live Nation Entertainment In Note 2.000% 2/1
Rivian Automotive Note 4.625% 3/1
Vishay Intertechnology Note 2.250% 6/1
Veeco Instrs Inc Del Note 2.875% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Snap Note 0.125% 3/0
Burlington Stores Note 2.250% 4/1
Ncl Corp Note 5.375% 8/0

View all positions for Alpine Partners VI

Top funds holding G1 Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Qube Research & Technologies
Morgan Stanley
Bridgeway Capital Management
Two Sigma Investments
Two Sigma Advisers
Goldman Sachs Group
PanAgora Asset Management
Nuveen Asset Management
Alpine Partners VI
Alliancebernstein
Cetera Investment Advisers
Tower Research Capital

View all funds holding G1 Therapeutics